Inkyong Parrack, MD
Vascular Surgery · Sarasota, FLNPI 1851539407
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $48,700 of the $80,174 with a category attached, or 60.7%. Silk Road Medical, Inc. accounts for 73.6% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2023 at $26,647 and has fallen 90.2% since, to $2,598 in 2025. Among vascular surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 352 payments — averaging $227.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$59K
- Medtronic$5K
- Penumbra, Inc.$3K
- Angiodynamics, Inc.$2K
- Philips North America LLC$2K
- W. L. Gore & Associates, Inc.$2K
- plus $6K from 24 others
What the payments were for
- Consulting fees$48,70061%
- Speaking & faculty fees$1,6882%
- Travel & lodging$11,27014%
- Food & beverage$16,09220%
- Other$2,4243%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 77 | $58,997 |
| Medtronic(2 entities) | 69 | $5,445 |
| Penumbra, Inc. | 45 | $2,983 |
| Angiodynamics, Inc. | 4 | $2,424 |
| Philips North America LLC | 11 | $2,329 |
| W. L. Gore & Associates, Inc. | 32 | $2,254 |
| Terumo Medical Corporation | 16 | $1,681 |
| Abbott | 36 | $1,050 |
| Bard Peripheral Vascular, Inc. | 6 | $1,008 |
| Boston Scientific | 12 | $480 |
| Johnson & Johnson | 11 | $294 |
| Kerecis Limited | 3 | $271 |
| Stryker | 3 | $172 |
| Cvrx, Inc. | 1 | $155 |
| Cardinal Health 200 LLC | 1 | $124 |
| Cardiva Medical, Inc. | 2 | $101 |
| Inari Medical, Inc. | 4 | $64 |
| Getinge USA Sales, LLC | 2 | $52 |
| Tactile Systems Technology Inc | 3 | $50 |
| Smith+Nephew | 2 | $35 |
| Mozarc Medical US LLC | 1 | $34 |
| Biocompatibles, Inc. | 2 | $29 |
| KCI USA, Inc. | 2 | $28 |
| Bristol Myers Squibb | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Lemaitre Vascular, Inc. | 1 | $19 |
| Shockwave Medical, Inc | 1 | $19 |
| Portola Pharmaceuticals, LLC | 1 | $16 |
| Pfizer | 1 | $15 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$59,748
- ENROUTE Transcarotid Stent$47,308
- ENHANCE Transcarotid Peripheral Access Kit$13,640
- ENROUTE Transcarotid Stent System$10,753
- ENROUTE 0.014 Guidewire$10,753
- ENROUTE .014 Guidewire$2,888
- Valiant Navion$2,672
- VenaCure 1470 Pro$2,400
- IGT D Peripheral$1,757
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$1,688
- Indigo System$1,143
- Navicross$999
- AZUR$999
- GlideWire$999
- Kerecis Omega3 SurgiClose$740
- ENDURANT IIS$645
- Indigo$631
- Valiant Captivia$540
- Penumbra System$469
- GORE TAG Thoracic Branch Endoprosthesis$276
How this compares
$80,174 in reported general payments places this provider in the 95th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 92 | $66,382 |
| XareltoRivaroxaban | 55 | $39,872 |
| BrilintaTicagrelor | 21 | $9,790 |
| Prasugrel Hcl | 19 | $2,060 |
| Cilostazol | 72 | $1,628 |
| ClopidogrelClopidogrel Bisulfate | 165 | $1,477 |
| Enoxaparin Sodium | 12 | $320 |
| Gabapentin | 17 | $105 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $73 |
| Oxycodone Hcl | 23 | $73 |
| Atorvastatin Calcium | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $66,38292 claims |
| Johnson & JohnsonXarelto | $294 | $39,87255 claims |
| AstraZenecaBrilinta | $20 | $9,79021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 385 vascular surgery providers in Florida.
Other vascular surgery in Sarasota
- Ryan SupleeSarasota$64K
- Jason WagnerSarasota$62K
- Russell SamsonSarasota$43K
- Samuel TapperStuart$1.3M
- Mariano ArosemenaBradenton$472K
- Manuel Perez IzquierdoOrlando$302K
- Erin MooreJacksonville$300K
- Rajesh MalikNaples$237K
- Charles BaileyTampa$162K
- Joseph WasselleMelbourne$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.